個別化医療とエピゲノムの世界市場:市場規模・現状・予測(2019-2025)

【英語タイトル】Global Personalized Medicine and Epigenomics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR9056221)・商品コード:QYR9056221
・発行会社(調査会社):QYResearch
・発行日:2019年8月7日
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD7,800 ⇒換算¥897,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当資料は、個別化医療とエピゲノムのグローバル市場について調査・分析したレポートで、種類別(試薬、キット、器械、酵素、サービス)、用途別(腫瘍学、非腫瘍学、抗がん剤技術)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・個別化医療とエピゲノムの世界市場規模
・主要企業別市場シェア
・個別化医療とエピゲノムの世界市場規模:種類別(試薬、キット、器械、酵素、サービス)
・個別化医療とエピゲノムの世界市場規模:用途別(腫瘍学、非腫瘍学、抗がん剤技術)
・個別化医療とエピゲノムのアメリカ市場規模(種類別、用途別)
・個別化医療とエピゲノムのヨーロッパ市場規模(種類別、用途別)
・個別化医療とエピゲノムの中国市場規模(種類別、用途別)
・個別化医療とエピゲノムの日本市場規模(種類別、用途別)
・個別化医療とエピゲノムの東南アジア市場規模(種類別、用途別)
・個別化医療とエピゲノムのインド市場規模(種類別、用途別)
・個別化医療とエピゲノムの中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・個別化医療とエピゲノムの世界市場予測(2019年-2025年)
・個別化医療とエピゲノムの地域別市場予測(2019年-2025年)
...
【レポートの概要】

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.In 2018, the global Personalized Medicine and Epigenomics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Personalized Medicine and Epigenomics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicine and Epigenomics development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
Roche Holding AG
Rubicon Genomics
Takeda Pharmaceutical Company Limited

Market segment by Type, the product can be split into
Reagents
Kits
Instruments
Enzymes
Services

Market segment by Application, split into
Oncology
Non-Oncology
Cancer Drug Technology

Market segment by Regions/Countries, this report covers
United States

【レポートの目次】

Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Personalized Medicine and Epigenomics status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicine and Epigenomics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Personalized Medicine and Epigenomics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Type (2014-2025)
1.4.2 Reagents
1.4.3 Kits
1.4.4 Instruments
1.4.5 Enzymes
1.4.6 Services
1.5 Market by Application
1.5.1 Global Personalized Medicine and Epigenomics Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Non-Oncology
1.5.4 Cancer Drug Technology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Personalized Medicine and Epigenomics Market Size
2.2 Personalized Medicine and Epigenomics Growth Trends by Regions
2.2.1 Personalized Medicine and Epigenomics Market Size by Regions (2014-2025)
2.2.2 Personalized Medicine and Epigenomics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Personalized Medicine and Epigenomics Market Size by Manufacturers
3.1.1 Global Personalized Medicine and Epigenomics Revenue by Manufacturers (2014-2019)
3.1.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Personalized Medicine and Epigenomics Market Concentration Ratio (CR5 and HHI)
3.2 Personalized Medicine and Epigenomics Key Players Head office and Area Served
3.3 Key Players Personalized Medicine and Epigenomics Product/Solution/Service
3.4 Date of Enter into Personalized Medicine and Epigenomics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Personalized Medicine and Epigenomics Market Size by Type (2014-2019)
4.2 Global Personalized Medicine and Epigenomics Market Size by Application (2014-2019)

5 United States
5.1 United States Personalized Medicine and Epigenomics Market Size (2014-2019)
5.2 Personalized Medicine and Epigenomics Key Players in United States
5.3 United States Personalized Medicine and Epigenomics Market Size by Type
5.4 United States Personalized Medicine and Epigenomics Market Size by Application

6 Europe
6.1 Europe Personalized Medicine and Epigenomics Market Size (2014-2019)
6.2 Personalized Medicine and Epigenomics Key Players in Europe
6.3 Europe Personalized Medicine and Epigenomics Market Size by Type
6.4 Europe Personalized Medicine and Epigenomics Market Size by Application

7 China
7.1 China Personalized Medicine and Epigenomics Market Size (2014-2019)
7.2 Personalized Medicine and Epigenomics Key Players in China
7.3 China Personalized Medicine and Epigenomics Market Size by Type
7.4 China Personalized Medicine and Epigenomics Market Size by Application

8 Japan
8.1 Japan Personalized Medicine and Epigenomics Market Size (2014-2019)
8.2 Personalized Medicine and Epigenomics Key Players in Japan
8.3 Japan Personalized Medicine and Epigenomics Market Size by Type
8.4 Japan Personalized Medicine and Epigenomics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Personalized Medicine and Epigenomics Market Size (2014-2019)
9.2 Personalized Medicine and Epigenomics Key Players in Southeast Asia
9.3 Southeast Asia Personalized Medicine and Epigenomics Market Size by Type
9.4 Southeast Asia Personalized Medicine and Epigenomics Market Size by Application

10 India
10.1 India Personalized Medicine and Epigenomics Market Size (2014-2019)
10.2 Personalized Medicine and Epigenomics Key Players in India
10.3 India Personalized Medicine and Epigenomics Market Size by Type
10.4 India Personalized Medicine and Epigenomics Market Size by Application

11 Central & South America
11.1 Central & South America Personalized Medicine and Epigenomics Market Size (2014-2019)
11.2 Personalized Medicine and Epigenomics Key Players in Central & South America
11.3 Central & South America Personalized Medicine and Epigenomics Market Size by Type
11.4 Central & South America Personalized Medicine and Epigenomics Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalized Medicine and Epigenomics Introduction
12.1.4 Abbott Laboratories Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Affymetrix
12.2.1 Affymetrix Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalized Medicine and Epigenomics Introduction
12.2.4 Affymetrix Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.2.5 Affymetrix Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalized Medicine and Epigenomics Introduction
12.3.4 Agilent Technologies Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.3.5 Agilent Technologies Recent Development
12.4 Astellas Pharmaceuticals
12.4.1 Astellas Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalized Medicine and Epigenomics Introduction
12.4.4 Astellas Pharmaceuticals Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.4.5 Astellas Pharmaceuticals Recent Development
12.5 BAYER AG
12.5.1 BAYER AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalized Medicine and Epigenomics Introduction
12.5.4 BAYER AG Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.5.5 BAYER AG Recent Development
12.6 Bio Vision
12.6.1 Bio Vision Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalized Medicine and Epigenomics Introduction
12.6.4 Bio Vision Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.6.5 Bio Vision Recent Development
12.7 Celgene Corp.
12.7.1 Celgene Corp. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalized Medicine and Epigenomics Introduction
12.7.4 Celgene Corp. Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.7.5 Celgene Corp. Recent Development
12.8 Emd Millipore
12.8.1 Emd Millipore Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalized Medicine and Epigenomics Introduction
12.8.4 Emd Millipore Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.8.5 Emd Millipore Recent Development
12.9 Epigenomics AG
12.9.1 Epigenomics AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalized Medicine and Epigenomics Introduction
12.9.4 Epigenomics AG Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.9.5 Epigenomics AG Recent Development
12.10 Epigentex
12.10.1 Epigentex Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalized Medicine and Epigenomics Introduction
12.10.4 Epigentex Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
12.10.5 Epigentex Recent Development
12.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
12.12 Gilead Sciences
12.13 Glaxosmithkline
12.14 Illumina Inc.
12.15 Johnson & Johnson
12.16 Karus Therapeutics Limited
12.17 Laboratory Corp. Of America Holdings
12.18 LES Laboratoires Servier
12.19 Merck
12.20 Naturewise Biotech & Medicals Corp.
12.21 Novartis Pharma AG
12.22 Oncolys Biopharma Inc.
12.23 Orchid Chemicals & Pharmaceuticals Limited
12.24 Progen Pharmaceuticals Limited
12.25 Quest Diagnostics
12.26 Roche Holding AG


13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
Table Global Microarrays and Lab-on-a-Chip Market Size by Type (2014-2019) (Million US$)
Table Global Microarrays and Lab-on-a-Chip Market Size Share by Type (2014-2019)
Figure Global Microarrays and Lab-on-a-Chip Market Size Market Share by Type (2014-2019)
Table Global Microarrays and Lab-on-a-Chip Market Size by Application (2014-2019) (Million US$)
Table Global Microarrays and Lab-on-a-Chip Market Size Share by Application (2014-2019)
15.3 Author Details
Figure Global Microarrays and Lab-on-a-Chip Revenue Market Share by Application in 2018

Table United States Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Table United States Key Players Microarrays and Lab-on-a-Chip Market Share (2018-2019)
Table Personalized Medicine and Epigenomics Key Market Segments
Table United States Microarrays and Lab-on-a-Chip Market Share by Type (2014-2019)
Table Global Personalized Medicine and Epigenomics Market Size Growth Rate by Type 2014-2025 (Million US$)
Table United States Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Figure Europe Microarrays and Lab-on-a-Chip Market Size 2014-2019 (Million US$)
Table Europe Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Table Europe Key Players Microarrays and Lab-on-a-Chip Market Share (2018-2019)
Table Europe Microarrays and Lab-on-a-Chip Market Size by Type (2014-2019) (Million US$)
Table Europe Microarrays and Lab-on-a-Chip Market Share by Type (2014-2019)
Table Europe Microarrays and Lab-on-a-Chip Market Size by Application (2014-2019) (Million US$)
Table Europe Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Figure China Microarrays and Lab-on-a-Chip Market Size 2014-2019 (Million US$)
Table China Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Table China Key Players Microarrays and Lab-on-a-Chip Market Share (2018-2019)
Table China Microarrays and Lab-on-a-Chip Market Size by Type (2014-20189) (Million US$)
Figure Oncology Case Studies
Table China Microarrays and Lab-on-a-Chip Market Size by Application (2014-2019) (Million US$)
Table China Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Figure Japan Microarrays and Lab-on-a-Chip Market Size 2014-2019 (Million US$)
Table Japan Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Figure Global Personalized Medicine and Epigenomics Market Size and Growth Rate 2014-2025 (Million US$)
Table Japan Microarrays and Lab-on-a-Chip Market Size by Type (2014-2019) (Million US$)
Table Japan Microarrays and Lab-on-a-Chip Market Share by Type (2014-2019)
Table Japan Microarrays and Lab-on-a-Chip Market Size by Application (2014-2019) (Million US$)
Table Japan Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Figure Southeast Asia Microarrays and Lab-on-a-Chip Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Microarrays and Lab-on-a-Chip Market Share (2018-2019)
Table Southeast Asia Microarrays and Lab-on-a-Chip Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Microarrays and Lab-on-a-Chip Market Share by Type (2014-2019)
Table Southeast Asia Microarrays and Lab-on-a-Chip Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Figure India Microarrays and Lab-on-a-Chip Market Size 2014-2019 (Million US$)
Table India Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Table India Key Players Microarrays and Lab-on-a-Chip Market Share (2018-2019)
Table India Microarrays and Lab-on-a-Chip Market Size by Type (2014-2019) (Million US$)
Table India Microarrays and Lab-on-a-Chip Market Share by Type (2014-2019)
Figure Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2014-2019)
Table India Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Figure Central & South America Microarrays and Lab-on-a-Chip Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Microarrays and Lab-on-a-Chip Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Microarrays and Lab-on-a-Chip Market Share (2018-2019)
Figure United States Personalized Medicine and Epigenomics Market Size 2014-2019 (Million US$)
Table United States Key Players Personalized Medicine and Epigenomics Revenue (2018-2019) (Million US$)
Table Central & South America Microarrays and Lab-on-a-Chip Market Size by Application (2014-2019) (Million US$)
Table Central & South America Microarrays and Lab-on-a-Chip Market Share by Application (2014-2019)
Table Agilent Technologies, Inc Company Details
Table Agilent Technologies, Inc Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019) (Million US$)
Figure Agilent Technologies, Inc Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Agilent Technologies, Inc Recent Development
Table Europe Key Players Personalized Medicine and Epigenomics Revenue (2018-2019) (Million US$)
Table Danaher Corporation Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure Danaher Corporation Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Danaher Corporation Recent Development
Table Becton, Dickinson and Company Company Details
Table Becton, Dickinson and Company Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure Becton, Dickinson and Company Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Becton, Dickinson and Company Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure Bio-Rad Laboratories Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Table Japan Key Players Personalized Medicine and Epigenomics Revenue (2018-2019) (Million US$)
Table Abbott Laboratories Recent Development
Table F. Hoffmann-La Roche Ag Company Details
Table F. Hoffmann-La Roche Ag Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Ag Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table F. Hoffmann-La Roche Ag Recent Development
Table Perkinelmer, Inc Company Details
Table Perkinelmer, Inc Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure Perkinelmer, Inc Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Southeast Asia Personalized Medicine and Epigenomics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Personalized Medicine and Epigenomics Market Share by Type (2014-2019)
Table Idex Corporation Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure Idex Corporation Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Idex Corporation Recent Development
Table India Key Players Personalized Medicine and Epigenomics Revenue (2018-2019) (Million US$)
Table Thermo Fisher Scientific, Inc Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Table India Personalized Medicine and Epigenomics Market Size by Type (2014-2019) (Million US$)
Table Thermo Fisher Scientific, Inc Recent Development
Table Raindance Technologies, Inc Company Details
Table Raindance Technologies, Inc Revenue in Microarrays and Lab-on-a-Chip Business (2014-2019)(Million US$)
Figure Raindance Technologies, Inc Revenue Growth Rate in Microarrays and Lab-on-a-Chip Business (2014-2019)
Table Raindance Technologies, Inc Recent Development
Table Fluidigm Corporation Company Details
Table Global Microarrays and Lab-on-a-Chip Market Size by Regions (Million US$) 2019-2025
Figure Global Microarrays and Lab-on-a-Chip Market Size Share by Regions (2019-2025)
Figure Global Microarrays and Lab-on-a-Chip Market Size Share by Regions in 2025
Figure United States Microarrays and Lab-on-a-Chip Market Size Forecast (2019-2025)(Million USD)
Figure Europe Microarrays and Lab-on-a-Chip Market Size Forecast (2019-2025)(Million USD)
Figure China Microarrays and Lab-on-a-Chip Market Size Forecast (2019-2025)(Million USD)
Figure Japan Microarrays and Lab-on-a-Chip Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Microarrays and Lab-on-a-Chip Market Size Forecast (2019-2025)(Million USD)
Figure India Microarrays and Lab-on-a-Chip Market Size Forecast (2019-2025)(Million USD)
Table Affymetrix Revenue in Personalized Medicine and Epigenomics Business (2014-2019)(Million US$)
Table Global Microarrays and Lab-on-a-Chip Market Size by Product (2019-2025) (Million US$)
Figure Global Microarrays and Lab-on-a-Chip Market Size by Product (2019-2025)
Table Agilent Technologies Company Details
Table Global Microarrays and Lab-on-a-Chip Market Size by Application (2019-2025) (Million US$)
Figure Global Microarrays and Lab-on-a-Chip Market Size by Application (2019-2025)
Figure Global Microarrays and Lab-on-a-Chip Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources






























Table LES Laboratoires Servier Company Details

Table Naturewise Biotech & Medicals Corp. Company Details




Table Quest Diagnostics Company Details
















Table Global Personalized Medicine and Epigenomics Market Size by Application (2019-2025) (Million US$)
Figure Global Personalized Medicine and Epigenomics Market Size by Application (2019-2025)








★調査レポート[個別化医療とエピゲノムの世界市場:市場規模・現状・予測(2019-2025)] (コード:QYR9056221)販売に関する免責事項を必ずご確認ください。
★調査レポート[個別化医療とエピゲノムの世界市場:市場規模・現状・予測(2019-2025)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆